학술논문
Guselkumab plus golimumab combination therapy versus guselkumab or golimumab monotherapy in patients with ulcerative colitis (VEGA): a randomised, double-blind, controlled, phase 2, proof-of-concept trial
Document Type
Article
Author
Tkachev, Alexander; Kalimullina, Dilara; Petryka, Robert; Osipenko, Marina; Tsarynna, Nataliia; Bilianskyi, Leonid; Kleczkowski, Dariusz; Yurkiv, Andrii; Woynarowski, Marek; Abrahamovych, Orest; Ivanishyn, Olha; Rydzewska, Grazyna; Kierkus, Jaroslaw; Petrova, Elina; Vasilevskaya, Olga; Afanasieva, Halyna; Francesconi, Carlos; Leszczyszyn, Jaroslaw; Bunkova, Elena; Platonov, Dmitry; Datsenko, Olena; Gridnyev, Oleksii; Hospodarsky, Ihor; Prystupa, Liudmyla; Stanislavchuk, Mykola; Pershko, Anatoly; Shchukina, Oksana; Simanenkov, Vladimir; Golovchenko, Oleksandr; Holderman, William; Lasa, Juan; Begun, Jakob; de Lourdes de Abreu Ferrari, Maria; Lopez, Pedro; Obrezan, Andrey; Farooq, Shiraz; Tiongco, Felix; Novillo, Abel; Tron, Emiliano; Macrae, Finlay; Leong, Rupert; Yukie Sassaki, Ligia; Zaltman, Cyrla; Kaiser Junior, Roberto; Stallmach, Andreas; Klaus, Jochen; Martinez, Manuel; Ruiz, Azalia; Abdulkhakov, Rustem; Sharma, Vishvinder; Korman, Louis; Lord, James; Patel, Bhaktasharan; Ritter, Timothy; Feagan, Brian G ; Sands, Bruce E; Sandborn, William J; Germinaro, Matthew; Vetter, Marion; Shao, Jie; Sheng, Shihong; Johanns, Jewel; Panés, Julián
Source
In The Lancet Gastroenterology & Hepatology April 2023 8(4):307-320
Subject
Language
ISSN
2468-1253